Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00588250
Recruitment Status : Terminated (Implantation rate significantly lower in treatment group than Controls.)
First Posted : January 8, 2008
Last Update Posted : April 8, 2015
Information provided by:
Mayo Clinic

Brief Summary:
Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.

Condition or disease Intervention/treatment Phase
Embryo Implantation Infertility Other: EmbryoGlue Not Applicable

Detailed Description:
EmbryoGlue (TM) is added to embryo transfer solutions immediately prior to the transfer of frozen-thawed human embryos before placement of embryos into the patient uterus.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Prospective Randomized Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates
Study Start Date : May 2003
Actual Primary Completion Date : June 2005
Actual Study Completion Date : June 2005

Arm Intervention/treatment
Experimental: A Other: EmbryoGlue
G2 culture media from Vitrolife which contains hyaluronic acid
No Intervention: B

Primary Outcome Measures :
  1. Pregnancy Rate [ Time Frame: one month ]

Secondary Outcome Measures :
  1. Implantation rate [ Time Frame: two months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Frozen embryo transfer patients, men over the age of 18 and women between the ages of 18 and 42 completed years (if using their own eggs and with embryos frozen before 39 completed years) or 18 to 50 completed years if using donated eggs.

Exclusion Criteria:

  • Prior participation in this study, blastocyst transfers, single embryo transfer for medical reasons, prior embryo transfer with large amount of blood on the outside of the catheter, > or = 3 consecutive failed embryo transfers at Mayo Clinic (fresh or frozen-thawed cycles).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00588250

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: Dean E Morbeck, PhD Mayo Clinic

Additional Information:
Responsible Party: Dean E. Morbeck, PhD, Mayo Clinic Identifier: NCT00588250     History of Changes
Other Study ID Numbers: 876-04
First Posted: January 8, 2008    Key Record Dates
Last Update Posted: April 8, 2015
Last Verified: April 2015

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female